Elanco US is a finished-dose manufacturer based in France. It appears in 425 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with DKMA (DK), Health Canada and MPA (SE). Its GMP standing is certified by ANSM (FR) and EMA. Its most recent recorded inspection, by US FDA, closed on 14 June 2018 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Basel, Switzerland | Not on file |
| France, France | Not on file |
| Huningue, France | Not on file |
| United Kingdom, United Kingdom | 3003701830 |
| Riyadh, Saudi Arabia | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| DKMA (DK) | 131 | None |
| Health Canada | 129 | None |
| MPA (SE) | 106 | None |
| NPRA (MY) | 31 | None |
| EMA | 22 | 1 |
| URPL (PL) | 5 | None |
| ANSM (FR) | None | 3 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2024 | $243.4M | Not reported | Not reported |
| 2023 | $260.0B | Not reported | Not reported |
| 2022 | $240.0B | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.
Choose your molecules and target markets. Elanco US comes back tiered against every other supplier able to file there.
Start for free